UBS Group’s ContraFect Corporation Class A Warrants CFRXW Stock Holding History

UBS Group’s Portfolio CFRXW Stock Details CFRXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,861	Closed	-$1K	–	8385
2016 Q4	$1K	Buy	+30,861	New	+$2.1K	﹤0.01%	7710
2016 Q2	–	Sell	-2,458	Closed	-$1K	–	8239
2016 Q1	$1K	Buy	2,458 +100	+4%	+$87	﹤0.01%	7528
2015 Q4	$3K	Buy	2,358 +320	+16%	+$473	﹤0.01%	7946
2015 Q3	$3K	Buy	2,038 +1,757	+625%	+$3.06K	﹤0.01%	8007
2015 Q2	$0	Sell	281 -147	-34%	-$238	﹤0.01%	9135
2015 Q1	$1K	Sell	428 -487	-53%	-$748	﹤0.01%	8647
2014 Q4	$1K	Buy	+915	New	+$576	﹤0.01%	9603

UBS Group's CFRXW Position: Q1 2017 in Review

UBS Group sold out of ContraFect Corporation Class A Warrants (CFRXW) in Q1 2017, closing a stake of 30,861 shares — an estimated $1K sold.

UBS Group first reported a position in CFRXW in Q4 2014 and held it in 7 quarters. The position peaked at $3K in Q4 2015. 0 funds tracked by Wall St. Rank hold CFRXW as of Q1 2017.

UBS Group reported no remaining ContraFect Corporation Class A Warrants position as of Q1 2017 after selling out during the quarter.
UBS Group sold 30,861 ContraFect Corporation Class A Warrants shares in Q1 2017, an estimated $1K.
UBS Group first reported a position in ContraFect Corporation Class A Warrants in Q4 2014 and held it in 7 quarters.
UBS Group's ContraFect Corporation Class A Warrants position peaked at $3K in Q4 2015.
0 funds tracked by Wall St. Rank held ContraFect Corporation Class A Warrants as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.